**Executive Summary**
This document details the Pradhan Mantri Bharatiya Janaushadhi Kendras (PMBJAK) scheme's implementation in Chhattisgarh. It outlines financial approvals for Mobile Medical Units (MMUs) and teleconsultation facilities for FY 2022-23 to FY 2024-25, and emphasizes strict quality control measures for medicines supplied to JAKs. The information was presented by the Minister of State for Chemicals and Fertilizers in the Lok Sabha.
**Key Points / Main Content**
**Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) in Chhattisgarh**
* As of February 28, 2026, 352 JAKs have been established in Chhattisgarh, with 73 located in aspirational districts.
**Financial Approvals for Healthcare Services in Chhattisgarh**
* **Mobile Medical Units (MMUs):**
* FY 2022-23: ₹558.00 lakh approved.
* FY 2023-24: ₹558.00 lakh approved.
* FY 2024-25: ₹2947.78 lakh approved.
* **Teleconsultation Facilities:**
* FY 2022-23: ₹409.50 lakh approved.
* FY 2023-24: ₹409.50 lakh approved.
* FY 2024-25: ₹409.50 lakh approved.
**Operational Details and Beneficiaries**
* **Mobile Medical Units (MMUs):**
* Supported under the National Health Mission (NHM) for outreach in remote, underserved areas.
* 30 MMUs were deployed in Chhattisgarh as of September 30, 2025.
* A total of 11,93,488 rural and tribal beneficiaries were covered under Rural Mobile Medical Unit (RMMU) (OPD) during FY 2024-25 and FY 2025-26 (until January 2026).
* **Teleconsultation Services:**
* Available at all operational Ayushman Arogya Mandir (AAM) facilities.
* Aims to improve access to specialist services, addressing physical accessibility and service provider shortages.
* As of January 31, 2026, 44.05 lakh teleconsultations were conducted in Chhattisgarh.
**Medicine Quality Control Measures for JAKs**
* **Supplier Eligibility:**
* Only supply from plants certified as WHO-GMP compliant by the Central Drugs Standard Control Organisation (CDSCO) after direct inspection.
* **Batch Testing:**
* 100% of medicine batches supplied to PMBI's warehouses undergo pre-testing.
* Medicines are dispatched for supply to JAKs only after passing quality tests.
* **Laboratory Standards:**
* Testing conducted only at labs accredited and periodically inspected by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
* Labs are also assessed by PMBI for Good Laboratory Practices (GLP) compliance.
**Regulatory Framework**
* Manufacture, sale, and distribution of drugs are regulated under the Drugs & Cosmetics Act & Rules, 1945.
* State Licensing Authorities issue licenses and conduct inspections.
* Drug Inspectors appointed by State and Central governments have powers to inspect premises, draw samples, and check drug quality.
* Controller Food and Drug Administration, Government of Chhattisgarh conducts regular inspections and sampling to ensure medicine quality and prevent spurious/substandard drugs.
**National Health Mission (NHM) Support**
* NHM provides support for health infrastructure, human resources, and improving availability, affordability, and accessibility of quality healthcare.
* Technical and financial support is provided to states/UTs to strengthen public healthcare in rural areas through Programme Implementation Plans (PIPs).
**Other Healthcare Initiatives**
* Operationalisation of Ayushman Arogya Mandir (AAM).
* Free Drugs Service Initiative, Free Diagnostic Service Initiative.
* National Ambulance Services, Mobile Medical Units, ASHAs.
* Prime Minister's National Dialysis Programme.
* Activities under Reproductive & Child Health, Anaemia Mukt Bharat (AMB) strategy, TB Mukt Bharat Abhiyaan, and Universal Immunization Programme.
* Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) with an outlay of ₹64,180 crore to support infrastructure development for various health facilities.
**XV-Finance Commission Recommendations**
* Grants aggregating to ₹70,051 crore recommended for the period 2021-2026 through Local Governments to strengthen healthcare systems in states.
**Impact Analysis**
**Citizens of Chhattisgarh (Patients)**
* **Impact:** Improved access to quality, affordable medicines through JAKs; enhanced healthcare services in remote and underserved areas via MMUs and teleconsultation; better quality assurance for medicines consumed.
* **Action Required:** Utilize the services offered by JAKs, MMUs, and teleconsultation facilities.
**Healthcare Providers in Chhattisgarh**
* **Impact:** Potential for increased patient reach through MMUs and teleconsultation; adherence to stringent quality standards for medicines supplied to JAKs.
* **Action Required:** Ensure compliance with medicine quality standards if supplying to PMBI warehouses or JAKs; utilize teleconsultation platforms.
**State Government of Chhattisgarh**
* **Impact:** Receives financial and technical support for healthcare infrastructure and services through NHM and other schemes; responsible for licensing and inspection of drug manufacturers and distributors; deployment and management of MMUs.
* **Action Required:** Continue to facilitate the implementation of PMBJP and associated healthcare initiatives; ensure regulatory compliance for drug quality and safety; manage operational aspects of MMUs and teleconsultation facilities.
**Ministry of Health and Family Welfare, Government of India**
* **Impact:** Oversees the implementation of PMBJP and NHM; provides financial and technical support to states; sets quality standards for medicines; approves Programme Implementation Plans (PIPs).
* **Action Required:** Continue to monitor and support the expansion and operationalization of PMBJP and related schemes in Chhattisgarh and other states.
**Ministry of Chemicals and Fertilizers, Government of India**
* **Impact:** The Ministry of State for Chemicals and Fertilizers provided the information regarding the XV-Finance Commission grants in a written reply to the Lok Sabha.
* **Action Required:** Continue to channel information and policy directives related to the chemical and pharmaceutical sectors influencing healthcare initiatives.
Key Entities Referenced
Pradhan Mantri Bharatiya Janaushadhi Pariyojana: A scheme under which Jan Aushadhi Kendras are opened across the country.
Ministry of Health and Family Welfare: A ministry that provides information and support for various health programs and infrastructure.
National Health Mission: A program that supports health infrastructure, human resources, and quality healthcare access.
Drugs & Cosmetics Act & Rules 1945: The primary regulation governing the manufacture, sale, and distribution of drugs in India.
Chhattisgarh: The specific state where the Pradhan Mantri Bharatiya Janaushadhi Kendras are being discussed.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Pradhan Mantri Bharatiya Janaushadhi Kendras
in Chhattisgarh
Posted On: 13 MAR 2026 3:43PM by PIB Delhi
Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, a total of 18,646 Jan Aushadhi Kendras
(JAKs) are opened across the country till 28.02.2026, of which 352 Kendras have been opened in the State
of Chhattisgarh including 73 in aspirational districts of the State.
As per information furnished by Ministry of Health and Family Welfare, details of the State Programme
Implementation Plan (SPIP) approvals on Mobile Medical Units (MMUs) and Teleconsultation facilities
for last three financial years for the State of Chhattisgarh are as under
Amount in ₹ lakh
F.Y. SPIP approval on Mobile Medical Units SPIP approval on
(MMUs) Teleconsultation facilities
2022-23 558.00 409.50
2023-24 558.00 409.50
2024-25 2947.78 409.50
Note: - The above data is as per Financial Management Record (FMR) submitted by States/UTs and is
provisional
Mobile Medical Units (MMUs) are supported under National Health Mission (NHM) to provide outreach
services in remote villages with difficult terrain which are underserved and inaccessible. As per NHM-
MIS report, 30 MMUs have been deployed in Chhattisgarh as on 30.09.2025.
The teleconsultation services, available at all operational Ayushman Arogya Mandir (AAM) across the
country including tribal regions of Chhattisgarh, enables people to access the specialist services closer to
their homes addressing concerns of physical accessibility, shortage of service providers and to facilitate
continuum of care. As reported by State on AAM portal, 44.05 lakh teleconsultations have been conducted
in Chhattisgarh as on 31.01.2026.
As informed by Directorate of Health Services, Government of Chhattisgarh, a total of 11,93,488 of
rural and tribal beneficiaries covered under Rural Mobile Medical Unit (RMMU) (OPD) during FY
2024-25 & 2025-26 (till January, 2026).
As per the information provided by Ministry of Health and Family Welfare, the manufacture, sale and
distribution of drugs are primarily regulated in the country under the provisions of Drugs & Cosmetics Act
& Rules 1945 made thereunder through a system of licensing and inspection by State LicensingAuthorities appointed by respective State Governments. Licensee is required to comply with all the
condition of license as prescribed under Drugs & Cosmetics Rules, 1945. Drugs manufactured in the
country, irrespective of branded or generic or for domestic or international market, are required to comply
with the same standards as prescribed in the Drugs and Cosmetics Act, 1940 and Rules, 1945 made
thereunder for their quality.
Further, The Inspectors appointed by the State and Central government under the Drugs and Cosmetics
Act, 1940 have powers to carry out inspection at the licensed premises and draw the sample of drugs from
supply chain and their quality be checked. In case, drug sample fails in quality checks and found to be Not
of standard quality/Spurious/Adulterated, the concerned Drugs Control Authority takes action under the
provisions of Drugs and Cosmetics Act and rules thereunder.
Also, Controller Food and Drug Administration, Government of Chhattisgarh has also informed that the
regular inspection and sampling is done by the Drug Inspectors within their respective jurisdictions to
ensure the quality of essential medicines, prevent the circulation of spurious and substandard drugs in the
market.
With a view to ensure quality of medicines available at JAKs so that health of patients is not
compromised, concrete mechanisms have been put in place to ensure continuous inspection, testing and
standardisation, including the following:
i. Supply only from WHO Good Manufacturing Practices (GMP) certified plants: Only plants
that are certified as WHO-GMP compliant by the Central Drugs Standard Control
Organisation (CDSCO) after direct inspection are eligible for supply.
ii. Distribution only after 100% pre-testing of all medicine batches: Samples are drawn from
100% of batches supplied at PMBI’s warehouses for testing anonymously, and medicines are
dispatched for supply to JAKs only after the quality test is passed.
iii. Testing only at labs compliant with Good Laboratory Practices (GLP): Samples are tested
only at labs accredited and periodically inspected by the National Accreditation Board for
Testing and Calibration Laboratories (NABL) and, in addition, assessed by PMBI for GLP
compliance.
Ministry of Health and Family Welfare has informed that the National Health Mission (NHM) provides
support for improvement in health infrastructure, availability of adequate human resources in health
facilities, to improve availability, affordability and accessibility to quality health care for all including
poor and vulnerable sections in urban, rural, and tribal/hilly areas including Chhattisgarh. The Ministry
of Health and Family Welfare provides technical and financial support to the States/UTs to strengthen the
public healthcare system in rural areas based on the proposals received in the form of Programme
Implementation Plans (PIPs) under National Health Mission. Government of India provides approval for
the proposal in the form of Record of Proceedings (RoPs) as per norms & available resources.
Various initiatives carried out under NHM by the Government of India in the country are
operationalisation of Ayushman Arogya Mandir (AAM), Free Drugs Service Initiative, Free Diagnostic
Service Initiative, National Ambulance Services, Mobile Medical Units, ASHAs, 24 x 7 Services and
First Referral Facilities, Prime Minister's National Dialysis Programme, various activities under
Reproductive & Child Health, Anaemia Mukt Bharat (AMB) strategy, TB Mukt Bharat Abhiyaan and
Universal Immunization programme.
The Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) with an outlay of
Rs.64,180 crore aims to support for infrastructure development for Sub-Health Centres, Urban Health and
Wellness Centres, Support for Block Public Health Units, Integrated District Public Health Laboratories
and Critical Care Hospital Blocks.The XV-Finance Commission has recommended grants aggregating to Rs.70,051 crore over the period
of five years (2021-2026) through Local Governments to strengthen the healthcare system in states.
This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a
written reply in the Lok Sabha today.
*****
PC/PM
(Release ID: 2239573) Visitor Counter : 87
Read this release in: Urdu , ही